Codexis Inc (CDXS)
3.815
+0.32
(+9.31%)
USD |
NASDAQ |
Nov 05, 16:00
3.82
0.00 (0.00%)
After-Hours: 20:00
Codexis Total Assets (Quarterly): 148.18M for Sept. 30, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
Date | Value |
---|---|
September 30, 2024 | 148.18M |
June 30, 2024 | 132.01M |
March 31, 2024 | 149.56M |
December 31, 2023 | 136.56M |
September 30, 2023 | 154.46M |
June 30, 2023 | 206.76M |
March 31, 2023 | 218.07M |
December 31, 2022 | 250.39M |
September 30, 2022 | 235.29M |
June 30, 2022 | 234.97M |
March 31, 2022 | 235.27M |
December 31, 2021 | 246.38M |
September 30, 2021 | 227.55M |
June 30, 2021 | 212.31M |
March 31, 2021 | 212.17M |
December 31, 2020 | 221.65M |
September 30, 2020 | 138.02M |
June 30, 2020 | 141.78M |
March 31, 2020 | 149.47M |
December 31, 2019 | 149.07M |
September 30, 2019 | 146.20M |
June 30, 2019 | 146.79M |
March 31, 2019 | 101.12M |
December 31, 2018 | 79.28M |
September 30, 2018 | 78.60M |
Date | Value |
---|---|
June 30, 2018 | 75.96M |
March 31, 2018 | 44.51M |
December 31, 2017 | 53.62M |
September 30, 2017 | 44.10M |
June 30, 2017 | 49.78M |
March 31, 2017 | 30.63M |
December 31, 2016 | 35.65M |
September 30, 2016 | 38.51M |
June 30, 2016 | 36.86M |
March 31, 2016 | 39.19M |
December 31, 2015 | 44.65M |
September 30, 2015 | 44.34M |
June 30, 2015 | 35.29M |
March 31, 2015 | 41.42M |
December 31, 2014 | 48.12M |
September 30, 2014 | 44.79M |
June 30, 2014 | 45.24M |
March 31, 2014 | 55.96M |
December 31, 2013 | 58.84M |
September 30, 2013 | 66.44M |
June 30, 2013 | 75.61M |
March 31, 2013 | 93.64M |
December 31, 2012 | 99.96M |
September 30, 2012 | 119.04M |
June 30, 2012 | 117.67M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
132.01M
Minimum
Jun 2024
250.39M
Maximum
Dec 2022
190.00M
Average
209.47M
Median
Total Assets (Quarterly) Benchmarks
Rhythm Pharmaceuticals Inc | 381.85M |
Allogene Therapeutics Inc | 646.88M |
Maravai LifeSciences Holdings Inc | 1.448B |
Artiva Biotherapeutics Inc | 90.16M |
CEL-SCI Corp | 24.07M |
Total Assets (Quarterly) Related Metrics
Total Liabilities (Quarterly) | 74.78M |
Shareholders Equity (Quarterly) | 73.40M |
Debt to Equity Ratio | 0.3901 |
Current Ratio | 3.214 |
Net Debt Paydown Yield | -2.28% |